Harriet S.MeyerMD, Contributing EditorJonathan D.EldredgeMLS, PhD, Journal Review EditorRobertHoganMD, adviser for new media
Copyright 2000 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2000American Medical Association
by the Committee on R & D Needs for Improving Civilian Medical Response to Chemical and Biological Terrorism Incidents, Health Science Policy Program, Institute of Medicine, and Board of Environmental Studies and Toxicology, Commission on Life Sciences, National Research Council, 279 pp, with illus, $44.95, ISBN 0-309-06195-4, Washington, DC, National Academy Press, 1999.
Concerned about possible terrorist incidents involving the use of biological and chemical agents, the Department of Health and Human Services' Office of Emergency Preparedness commissioned the Institute of Medicine (IOM) to examine the state of civilian medical capabilities and recommend additional research and development (R and D) to counter such incidents. In 1999, the IOM issued its interesting report, which makes eight general recommendations and identifies a number of specific R and D efforts under each. Eleven chapters of the report cover relevant legislation, intelligence and communications, protective equipment, detection and surveillance methods, decontamination and triage, currently available drugs and therapies, the psychological effects of terrorism, and computer models and training.
TerrorismChemical and Biological Terrorism: Research and Development to Improve Civilian Medical Response. JAMA. 2000;283(15):2035-2036. doi:10.1001/jama.283.15.2035